Meierjohann S - Search Results

1

Vemurafenib induces senescence features in melanoma cells.

Haferkamp S, Borst A, Adam C, Becker TM, Motschenbacher S, Windhövel S, Hufnagel AL, Houben R, Meierjohann S. Haferkamp S, et al. Among authors: meierjohann s. J Invest Dermatol. 2013 Jun;133(6):1601-9. doi: 10.1038/jid.2013.6. Epub 2013 Feb 14. J Invest Dermatol. 2013. PMID: 23321925 Free article.

2

Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence.

Leikam C, Hufnagel A, Schartl M, Meierjohann S. Leikam C, et al. Among authors: meierjohann s. Oncogene. 2008 Nov 27;27(56):7070-82. doi: 10.1038/onc.2008.323. Epub 2008 Sep 22. Oncogene. 2008. PMID: 18806824

3

A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies.

Schartl M, Wilde B, Laisney JA, Taniguchi Y, Takeda S, Meierjohann S. Schartl M, et al. Among authors: meierjohann s. J Invest Dermatol. 2010 Jan;130(1):249-58. doi: 10.1038/jid.2009.213. J Invest Dermatol. 2010. PMID: 19609310 Free article.

4

MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.

Meierjohann S, Hufnagel A, Wende E, Kleinschmidt MA, Wolf K, Friedl P, Gaubatz S, Schartl M. Meierjohann S, et al. Mol Cancer. 2010 Jul 28;9:201. doi: 10.1186/1476-4598-9-201. Mol Cancer. 2010. PMID: 20667128 Free PMC article.

5

Cystathionase mediates senescence evasion in melanocytes and melanoma cells.

Leikam C, Hufnagel A, Walz S, Kneitz S, Fekete A, Müller MJ, Eilers M, Schartl M, Meierjohann S. Leikam C, et al. Among authors: meierjohann s. Oncogene. 2014 Feb 6;33(6):771-82. doi: 10.1038/onc.2012.641. Epub 2013 Jan 28. Oncogene. 2014. PMID: 23353821

6

Oxidative stress in melanocyte senescence and melanoma transformation.

Meierjohann S. Meierjohann S. Eur J Cell Biol. 2014 Jan-Feb;93(1-2):36-41. doi: 10.1016/j.ejcb.2013.11.005. Epub 2013 Nov 23. Eur J Cell Biol. 2014. PMID: 24342719 Review.

7

The MAPK pathway as an apoptosis enhancer in melanoma.

Haydn JM, Hufnagel A, Grimm J, Maurus K, Schartl M, Meierjohann S. Haydn JM, et al. Among authors: meierjohann s. Oncotarget. 2014 Jul 15;5(13):5040-53. doi: 10.18632/oncotarget.2079. Oncotarget. 2014. PMID: 24970815 Free PMC article.

8

In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.

Leikam C, Hufnagel AL, Otto C, Murphy DJ, Mühling B, Kneitz S, Nanda I, Schmid M, Wagner TU, Haferkamp S, Bröcker EB, Schartl M, Meierjohann S. Leikam C, et al. Among authors: meierjohann s. Cell Death Dis. 2015 Apr 2;6(4):e1711. doi: 10.1038/cddis.2015.71. Cell Death Dis. 2015. PMID: 25837487 Free PMC article.

9

Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling.

Schmitt A, Schmitz W, Hufnagel A, Schartl M, Meierjohann S. Schmitt A, et al. Among authors: meierjohann s. Biochem J. 2015 Oct 15;471(2):267-79. doi: 10.1042/BJ20141204. Epub 2015 Aug 18. Biochem J. 2015. PMID: 26285655

10

Crosstalk signaling in targeted melanoma therapy.

Meierjohann S. Meierjohann S. Cancer Metastasis Rev. 2017 Mar;36(1):23-33. doi: 10.1007/s10555-017-9659-z. Cancer Metastasis Rev. 2017. PMID: 28197745 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters